Biotechnology and Medical Research (TRBC)

China tells medical institutions to stop using Huahai heart drug

China tells medical institutions to stop using Huahai heart drug

Published 30/07/2018

SHANGHAI (Reuters) - China’s health regulator has ordered local medical institutions to stop using a heart drug from Zhejiang Huahai Pharmaceutical Co Ltd, in a [more…]

FDA declines to approve Insys Therapeutic’s opioid painkiller

FDA declines to approve Insys Therapeutic’s opioid painkiller

Published 27/07/2018

(Reuters) - Insys Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its opioid painkiller, citing potential safety concerns. Insys [more…]

China police probe vaccine maker after scandal sparks fury

China police probe vaccine maker after scandal sparks fury

Published 23/07/2018

SHANGHAI (Reuters) - A vaccine scandal in China, which has prompted angry reactions from citizens fed up with safety scares, is sending ripples across the [more…]

China police probe vaccine maker Changsheng Bio-technology: Xinhua

China police probe vaccine maker Changsheng Bio-technology: Xinhua

Published 23/07/2018

BEIJING (Reuters) - Chinese police are investigating vaccine maker Changsheng Bio-technology Co Ltd after the firm was found to have faked documents related to a [more…]

Agios Pharmaceuticals leukemia drug gets U.S. approval

Agios Pharmaceuticals leukemia drug gets U.S. approval

Published 20/07/2018

(Reuters) - Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted [more…]

Israeli firm gets U.S. nod for advanced trials for non-opiate…

Israeli firm gets U.S. nod for advanced trials for non-opiate…

Published 10/07/2018

JERUSALEM (Reuters) - Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a [more…]

CTI Biopharma’s cancer drug fails late-stage trial, shares tumble

CTI Biopharma’s cancer drug fails late-stage trial, shares tumble

Published 09/07/2018

(Reuters) - CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage [more…]

Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial,…

Biogen, Eisai’s Alzheimer’s drug succeeds in mid-stage trial,…

Published 06/07/2018

(Reuters) - Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer’s drug showed positive results [more…]

U.S. approves first marijuana plant-derived drug for epilepsy

U.S. approves first marijuana plant-derived drug for epilepsy

Published 26/06/2018

(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the [more…]

Merrimack to scrap development of pancreatic cancer treatment

Merrimack to scrap development of pancreatic cancer treatment

Published 25/06/2018

(Reuters) - Merrimack Pharmaceuticals Inc said on Monday it would stop developing its experimental treatment for pancreatic cancer after it failed to meet the main [more…]